Panther Life Sciences
PrivateLast Round
Seed
Sep 25, 2023
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Panther Life Sciences operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Seed round in September 2023.
Panther Life Sciences is a biotechnology company that develops and commercializes microarray patch (MAP) technology for the shelf-stable, direct-to-consumer delivery of skin-based and immune-mediated treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Fashion & Beauty, D2C Brands
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Panther Life Sciences Comparables
Compare Panther Life Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PinPrint, Inc. | 88% | |
| ArrayPatch Ltd | 83% | |
| CeraVx B.V. | 83% |
For institutional investors. Book with your work email.
Panther Life Sciences Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Panther Life Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Helena Special Investments | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 2, 2026
Open roles increased to 22, 96% of headcount.
- Nov 1, 2026
Open roles increased to 12, 52% of headcount.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingSep 11, 2026
Panther Life Sciences Corporation is developing an intradermal drug-delivery platform using its SmartPatch technology to deliver therapeutics through the skin, with an AI-based platform supporting product development and personalized treatment; it is ready to deploy SmartPatch in 2027.
- hiresSep 9, 2026
Panther Life Sciences Corporation appoints Marcus "Mounir" Hanana as Chief Executive Officer on Sep 9th '26 in New York as it begins commercializing its SmartPatch platform.
For institutional investors. Book with your work email.
Panther Life Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Panther Life Sciences's valuation, stock price, and market status.
Is Panther Life Sciences a public or private company?
Panther Life Sciences is a private company.
What is the current stock price of Panther Life Sciences?
Panther Life Sciences is a private company, so its shares have no public market price. Caplight tracks Panther Life Sciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Panther Life Sciences worth (valuation)?
Valuation information for Panther Life Sciences is not publicly available.
Can I buy Panther Life Sciences stock?
Panther Life Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Panther Life Sciences's last funding round?
Panther Life Sciences's most recent funding round was Seed on September 25, 2023.
Who are the main investors in Panther Life Sciences?
Key investors in Panther Life Sciences include Helena Special Investments.
Will Panther Life Sciences IPO soon?
No public IPO plans have been announced for Panther Life Sciences.
How can I track Panther Life Sciences secondary market activity?
Caplight tracks bids, offers, and trades in Panther Life Sciences's shares on secondary markets.